Content
92%Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
The content is lean, highly actionable, and presents a clear single-pass analytical workflow with concrete thresholds and an output template, but it is a monolithic document that would benefit from splitting its reference tables into separate files.
Suggestions
Move the large threshold/signal tables (恐贪指数, PCR, 融资融券, 北向资金) into a reference file (e.g. references/indicators.md) and keep SKILL.md as an overview with one-level-deep links, improving progressive_disclosure.
Add an explicit verification step in the workflow (e.g. "Confirm at least 3 of 5 dimensions agree before mapping to a position") to make the cross-validation checkpoint a concrete numbered step.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | The body is information-dense — concrete threshold tables, formulas, and an output template — and avoids lecturing on concepts Claude already knows (only one-line definitional asides like "融资 = 借钱买股"), matching the lean score-3 anchor. | 3 / 3 |
Actionability | It provides specific operational thresholds (e.g. "融资余额月增>10% → 过热警示"), the weighted scoring formula, a position-mapping table, and a copy-paste-ready markdown output template; per the instruction-only scoring note, the absence of executable code is not penalized when guidance is this concrete. | 3 / 3 |
Workflow Clarity | A single, unambiguous analytical workflow — gather each indicator → normalize → weighted sum → map to position → fill the output template — with explicit cross-validation guidance in 注意事项 ("与融资余额、ETF申赎交叉验证") serving as a checkpoint. | 3 / 3 |
Progressive Disclosure | At ~268 lines with no bundle files, it is well-sectioned but monolithic: large inline reference tables (恐贪/PCR/融资/北向 thresholds) that could be split into separate reference files are kept inline, matching the score-2 anchor of structure present but content that should be separate is inline. | 2 / 3 |
Total | 11 / 12 Passed |